These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 1544384)
1. Hemopoietic neoplasms in lethally irradiated mice repopulated with bone marrow cells carrying the human c-myc oncogene: a repopulation assay. Hirabayashi Y; Inoue T; Suda Y; Aizawa S; Ikawa Y; Kanisawa M Exp Hematol; 1992 Feb; 20(2):167-72. PubMed ID: 1544384 [TBL] [Abstract][Full Text] [Related]
2. A non-transgenic mouse model for B-cell lymphoma: in vivo infection of p53-null bone marrow progenitors by a Myc retrovirus is sufficient for tumorigenesis. Yu D; Thomas-Tikhonenko A Oncogene; 2002 Mar; 21(12):1922-7. PubMed ID: 11896625 [TBL] [Abstract][Full Text] [Related]
3. H-2/myc, E mu/myc, and c-myc transgenic mice: potent sources of early hematopoietic cell lines. Roland J; Morello D Cell Growth Differ; 1993 Nov; 4(11):891-900. PubMed ID: 8297795 [TBL] [Abstract][Full Text] [Related]
4. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo. Lavenu A; Pournin S; Babinet C; Morello D Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263 [TBL] [Abstract][Full Text] [Related]
5. A multicopy c-Myc transgene as a nuclear label: overgrowth of Myctg50 cells in allophenic mice. Augustin M; Klopp N; Ewald K; Jockusch H Cell Biol Int; 1998; 22(6):401-11. PubMed ID: 10328848 [TBL] [Abstract][Full Text] [Related]
6. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice. Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076 [TBL] [Abstract][Full Text] [Related]
7. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha. Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981 [TBL] [Abstract][Full Text] [Related]
8. Experimental manipulations and marrow-derived factors which affect the outcome of bone marrow transplantation across the H-2 barrier in lethally irradiated mice. Pierpaoli W; Kellerhals R; Buehler A; Sache E J Clin Lab Immunol; 1985 Mar; 16(3):115-24. PubMed ID: 3897543 [TBL] [Abstract][Full Text] [Related]
9. A new transgenic mouse model for the study of cell cycle control in megakaryocytes. Thompson A; Zhao Z; Ladd D; Zimmet J; Ravid K Stem Cells; 1996; 14 Suppl 1():181-7. PubMed ID: 11012219 [TBL] [Abstract][Full Text] [Related]
10. Hemopoietic activity in bone marrow chimeras prepared with total lymphoid irradiation (TLI). Slavin S; Seidel HJ Exp Hematol; 1982 Feb; 10(2):206-16. PubMed ID: 7037437 [TBL] [Abstract][Full Text] [Related]
11. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats. Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347 [TBL] [Abstract][Full Text] [Related]
12. Leukemia inhibitory factor induces in vivo expansion of bone marrow progenitor cells that accelerate hematopoietic reconstitution but do not enhance radioprotection in lethally irradiated mice. Pruijt JF; Lindley IJ; Heemskerk DP; Willemze R; Fibbe WE Stem Cells; 1997; 15(1):50-5. PubMed ID: 9007222 [TBL] [Abstract][Full Text] [Related]
13. Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus. Blasi E; Radzioch D; Merletti L; Varesio L Cancer Biochem Biophys; 1989 Oct; 10(4):303-17. PubMed ID: 2695237 [TBL] [Abstract][Full Text] [Related]
14. Intra-bone marrow injection of donor bone marrow cells suspended in collagen gel retains injected cells in bone marrow, resulting in rapid hemopoietic recovery in mice. Shi M; Adachi Y; Shigematsu A; Koike-Kiriyama N; Feng W; Yanai S; Yunze C; Lian ZX; Li J; Ikehara S Stem Cells; 2008 Sep; 26(9):2211-6. PubMed ID: 18599811 [TBL] [Abstract][Full Text] [Related]
15. AID and RAG1 do not contribute to lymphomagenesis in Emu c-myc transgenic mice. Nepal RM; Zaheen A; Basit W; Li L; Berger SA; Martin A Oncogene; 2008 Aug; 27(34):4752-6. PubMed ID: 18408759 [TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative syndrome associated with c-myc expression driven by a class I gene promoter in transgenic mice. Morello D; Lavenu A; Bandeira A; Portnoi D; Gaillard J; Babinet C Oncogene Res; 1989; 4(2):111-25. PubMed ID: 2654814 [TBL] [Abstract][Full Text] [Related]
17. Transformation of bone marrow cells from E mu-myc transgenic mice by Abelson murine leukemia virus and Harvey murine sarcoma virus. Dyall-Smith D; Cory S Oncogene Res; 1988 May; 2(4):403-9. PubMed ID: 2840624 [TBL] [Abstract][Full Text] [Related]
18. Expression of N-myc, c-myc, and MDR-1 proteins in newly established neuroblastoma cell lines: a study by immunofluorescence staining and flow cytometry. Gazitt Y; He YJ; Chang L; Koza S; Fisk D; Graham-Pole J Cancer Res; 1992 May; 52(10):2957-65. PubMed ID: 1374683 [TBL] [Abstract][Full Text] [Related]
19. AlphaIIb integrin expression during development of the murine hemopoietic system. Corbel C; Salaün J Dev Biol; 2002 Mar; 243(2):301-11. PubMed ID: 11884039 [TBL] [Abstract][Full Text] [Related]
20. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation. Tam YK; Klingemann HG Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]